Evidence map›Paper›PMID 39423357›Full record

ReviewArchivos de cardiologia de Mexico2024

Obesity and cardiovascular risk: a primer for the clinician.

Diego Araiza-Garaygordobil, Mariana García-Villarejo, Mauricio González-Arias

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Archivos de cardiologia de Mexico, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Diego Araiza-GaraygordobilUnidad Coronaria, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México.
Mariana García-VillarejoUnidad Coronaria, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México.
Mauricio González-AriasEmergency Department, Metropolitan Hospital Center, New York Medical College, New York City, EE.UU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a significant risk factor for the development of cardiovascular diseases. This review addresses the complex interaction between obesity and cardiovascular risk, highlighting dysfunctional adiposity as a crucial precursor in the metabolic renal cardiovascular continuum. The underlying pathophysiological mechanisms are reviewed, emphasizing the importance of risk identification and proper stratification, as well as the various available treatment strategies, including pharmacological and non-pharmacological interventions that have proven to reduce cardiovascular risk. Practical tools and evidence-based strategies are provided to enhance clinical management and cardiovascular health outcomes in this particularly vulnerable patient population.

Indexed as

Cardiovascular DiseasesObesityHeart Disease Risk FactorsHumansRisk FactorsCardiovascular diseaseDysfunctional adiposityNon-pharmacological treatmentObesityPharmacological treatmentRisk stratification

Identifiers

PMID39423357
PMCPMC12148517

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.